News | 09 August 2012
While generics will eat into sales, new products are not expected to generate the same level of sales as products losing patent protection. The next few years are expected to reflect a significant imbalance between new product introductions and patent ...
Click on the link to read the full article at NASDAQ
(This link will open in a new window)